Rivastigmine 70710-1196-07
- Manufacturer
- Zydus Pharmaceuticals Usa Inc.
- Dosage Form
- Patch, Extended Release
- Route
- Transdermal
- Product Type
- Human Prescription Drug
- Marketing Start
- March 6, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA206318
Need to source Rivastigmine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Rivastigmine | 4.6 mg/24h |
Drug Class
Cholinesterase Inhibitor [EPC]Cholinesterase Inhibitor [EPC]Cholinesterase Inhibitors [MoA]
Selected Package
70710-1196-07Selected30 POUCH in 1 CARTON (70710-1196-7) / 24 h in 1 POUCH (70710-1196-1)